Expression of terminal deoxynucleotidyl transferase (TdT) in classical seminoma: a potential diagnostic pitfall.
Alexander BrobeilFlorian WagenlehnerStefan GattenlöhnerPublished in: Virchows Archiv : an international journal of pathology (2018)
Seminomas are the most frequent testicular tumors and in spite of specific markers some histological subtypes can be diagnostically challenging due to the potential overlap of morphologic features and a variant antigen expression. Terminal deoxynucleotidyl transferase (TdT) is a DNA polymerase present in hematogones, thymic T cells, lymphoblastic lymphoma/leukemia (LBL), and in some cases of acute myeloid leukemia but so far has not been described to be expressed in seminomas. After observing a reactivity of TdT in one case of seminoma, we analyzed ten additional tumors by immunohistochemistry to determine their spectrum of reactivity for TdT. In all seminoma cases investigated (10/10) as well as in two tumor-associated germ cell neoplasias in situ (2/2) the TdT staining intensity was variable but was often moderate to strong and restricted to the nucleus. We conclude that TdT expression in seminomas could represent a diagnostic pitfall in the differential diagnosis of LBL, particularly because both may lack CD45 and/or CD20 expression and-concerning relapse in long-term survivors of testicular cancer-LBL is the most frequent secondary neoplasm in the patients.
Keyphrases
- germ cell
- poor prognosis
- acute myeloid leukemia
- end stage renal disease
- high intensity
- binding protein
- bone marrow
- chronic kidney disease
- newly diagnosed
- young adults
- climate change
- mass spectrometry
- risk assessment
- human health
- papillary thyroid
- allogeneic hematopoietic stem cell transplantation
- single molecule
- peritoneal dialysis
- high speed
- childhood cancer